Defendant entity record

Purdue Pharma

OxyContin maker; twice a federal felon — 2007 misbranding, 2020 fraud and kickback conspiracies — with a $5.5 billion criminal sentence imposed in 2026 within the opioid settlement architecture.

Ticker (private; in bankruptcy)Facts verified Jul 19, 2026

The record

Key facts

Fact 01

2 — federal felony guilty pleas (2007 misbranding; 2020 fraud/kickbacks)

Source: https://www.justice.gov/archives/opa/pr/opioid-manufacturer-purdue-pharma-pleads-guilty-fraud-and-kickback-conspiracies

Fact 02

$5.5B — criminal sentence imposed April 2026

Source: https://www.justice.gov/

Fact 03

76B — opioid pills in the ARCOS data unsealed via the MDL

Source: https://www.washingtonpost.com/

The entity

Record

Purdue's criminal record is adjudicated fact, not allegation: in 2007 the company pleaded guilty to felony misbranding of OxyContin — marketing it as less addictive while knowing its abuse potential resembled morphine — and in 2020 pleaded guilty again to fraud and kickback conspiracies. The associated $5.5 billion sentence was imposed in April 2026 as part of the broader opioid resolution.

The national opioid litigation surrounding Purdue produced one of the great transparency outcomes in mass-tort history: court fights led by news organizations unsealed the DEA's ARCOS shipment database — 76 billion opioid pills tracked to the county level — and settlement terms created the public Opioid Industry Documents Archive.

Purdue's bankruptcy has been litigated to the Supreme Court and back over releases for the Sackler family; the plan architecture continued evolving through 2026. Docket specifics belong to the bankruptcy court record.

Public-record events

Timeline

Sources & attribution

Sources cited